Diagnostic Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT and 131I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

Medicine, Nuclear Medicine, Radiology +15

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Functional imaging of neuroendocrine tumors with combined PET/CT using ⁶⁸Ga‐DOTATATE (DOTA‐<scp>D</scp>Phe¹,Tyr³‐octreotate) and ¹⁸F‐FDG

Irfan Kayani, Jamshed Bomanji, Ashley M. Groves et al. · Cancer · 2008 · 466 citations · Full text

Medicine, Oncology, Radiology +17

Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas

Laurence Amar, Éric Baudin, Nelly Burnichon et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 444 citations

Medicine, Oncology, Pathology +14